ストックスクリーナーアプリを入手
3.545
1.29%
0.045
前日終値:
$3.50
開ける：
$3.52
24時間の取引高:
428.01K
Relative Volume:
0.30
時価総額：
$349.47M
収益：
$775.09M
当期純損益:
$-58.68M
株価収益率:
-26.73
EPS:
-0.1326
ネットキャッシュフロー:
$64.06M
1週間 パフォーマンス:
-18.32%
1か月 パフォーマンス:
-25.29%
6か月 パフォーマンス:
-29.52%
1年 パフォーマンス:
-48.40%
1日の値動き範囲:
$3.4612
$3.56
1週間の範囲:
$3.305
$4.00
52週間の値動き範囲:
$3.305
$8.80
Goodrx Holdings Inc Stock (GDRX) Company Profile
名前
Goodrx Holdings Inc
セクター
電話
(855) 268-2822
住所
2701 OLYMPIC BOULEVARD, SANTA MONICA
GDRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.545 | 1.21B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
278.00 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
70.89 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
63.01 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.02 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-08-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-02 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-08-10 | アップグレード | DA Davidson | Neutral → Buy |
| 2023-07-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 開始されました | Citigroup | Buy |
| 2022-11-04 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-12 | 開始されました | DA Davidson | Neutral |
| 2022-06-10 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-06 | 再開されました | BofA Securities | Buy |
| 2022-06-01 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 開始されました | Wells Fargo | Equal Weight |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2022-03-15 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 繰り返されました | Barclays | Overweight |
| 2022-03-01 | 繰り返されました | BofA Securities | Neutral |
| 2022-03-01 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-03-01 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 繰り返されました | Evercore ISI | Outperform |
| 2022-03-01 | 繰り返されました | Goldman | Buy |
| 2022-03-01 | 繰り返されました | JP Morgan | Underweight |
| 2022-03-01 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-03-01 | 繰り返されました | SVB Leerink | Outperform |
| 2022-01-07 | 開始されました | Goldman | Buy |
| 2021-12-21 | 開始されました | Stephens | Overweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-08-31 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-08-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-06 | 再開されました | Evercore ISI | Outperform |
| 2021-01-25 | 開始されました | Guggenheim | Buy |
| 2020-11-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 開始されました | Barclays | Equal Weight |
| 2020-10-19 | 開始されました | BofA Securities | Neutral |
| 2020-10-19 | 開始されました | Citigroup | Buy |
| 2020-10-19 | 開始されました | Cowen | Outperform |
| 2020-10-19 | 開始されました | Credit Suisse | Outperform |
| 2020-10-19 | 開始されました | Deutsche Bank | Hold |
| 2020-10-19 | 開始されました | Goldman | Neutral |
| 2020-10-19 | 開始されました | JP Morgan | Neutral |
| 2020-10-19 | 開始されました | Morgan Stanley | Overweight |
| 2020-10-19 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 開始されました | SVB Leerink | Outperform |
| 2020-10-19 | 開始されました | UBS | Buy |
すべてを表示
Goodrx Holdings Inc (GDRX) 最新ニュース
GoodRx Earnings Call: Growth Amid Challenges - TipRanks
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2025 Earnings Call Transcript - Insider Monkey
GoodRx stock price target lowered to $4.25 from $5.25 at UBS - Investing.com Australia
GoodRx Holdings Inc. (GDRX) PT Lowered to $4.25 at UBS - StreetInsider
Deutsche Bank Adjusts GoodRx Price Target to $6 From $8, Maintains Hold Rating - MarketScreener
Raymond James Downgrades GoodRx Holdings to Outperform From Strong Buy, Adjusts Price Target to $5 From $9 - MarketScreener
GoodRx Holdings: Buy Rating Maintained Despite Short-term Adjustments - AInvest
GoodRx Holdings Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
GoodRx Holdings Inc. stock chart pattern explainedVolume Confirmed Setup with Entry Confidence - Newser
Using AI based signals to follow GoodRx Holdings Inc.AI-Based Reversal Point Prediction Signal - Newser
Earnings visualization tools for GoodRx Holdings Inc.Weekly Market Direction and Sector Summary - Newser
How to integrate GoodRx Holdings Inc. into portfolio analysis toolsShort-Term AI-Based Stock Price Forecast - Newser
How GoodRx Holdings Inc. stock performs during market volatilityWealth Accumulation Outlook for Safe Investors - Newser
Statistical indicators supporting GoodRx Holdings Inc.’s strengthWeekly Return Plan for Conservative Traders - Newser
GoodRx downgraded to Outperform from Strong Buy at Raymond James - TipRanks
GoodRx stock downgraded by Raymond James on guidance cut after Rite Aid closures - Investing.com South Africa
Raymond James Downgrades GoodRx Holdings Inc. (GDRX) to Outperform - StreetInsider
Transcript : GoodRx Holdings, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
GoodRx stock falls as Morgan Stanley cuts price target on retail challenges By Investing.com - Investing.com South Africa
GoodRx stock falls as Morgan Stanley cuts price target on retail challenges - Investing.com Canada
Morgan Stanley Cuts Price Target on GoodRx Holdings to $5 From $6, Keeps Equalweight Rating - MarketScreener
Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding - simplywall.st
GoodRx Holdings Inc. (GDRX) PT Lowered to $5 at Morgan Stanley - StreetInsider
Goldman Sachs lowers GoodRx stock price target on healthcare headwinds By Investing.com - Investing.com Australia
Goldman Sachs lowers GoodRx stock price target on healthcare headwinds - Investing.com India
Analysts Weigh In on GoodRx Holdings (GDRX) and Arcutis Biotherapeutics (ARQT) - AInvest
GoodRx Q2 Earnings Fall Short of Expectations with EPS at 4c - AInvest
Forecasting GoodRx Holdings Inc. price range with options dataTechnical Chart Summary for Momentum Stocks - Newser
GoodRx Holdings Inc. (GDRX) PT Lowered to $3.75 at Goldman Sachs - StreetInsider
GoodRx (NASDAQ:GDRX) Hits New 1-Year Low After Earnings Miss - Defense World
GoodRx Holdings Inc (GDRX) Q2 2025 Earnings Call Highlights: Str - GuruFocus
GoodRx Reports Steady Q2 2025 Financial Results - TipRanks
GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Lag Estimates - MSN
Compared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics - MSN
Goodrx stock hits 52-week low at $3.67 By Investing.com - Investing.com South Africa
Goodrx stock hits 52-week low at $3.67 - Investing.com
GoodRx Misses Forecasts But Sees Growth Ahead In 2025 - Finimize
GoodRx Misses Targets But Pharma Unit Powers Growth - Finimize
Decoding GoodRx Holdings Inc (GDRX): A Strategic SWOT Insight - GuruFocus
GoodRx Holdings, Inc. Q2 Profit Increases, But Misses Estimates - Nasdaq
GoodRx Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Judge refuses to let Meta and Google off the hook in GoodRx health data sharing lawsuit - Class Action Lawsuits
Digital healthcare firm GoodRx Q2 revenue misses estimates - MarketScreener
GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 1c - StreetInsider
GoodRx Q2 2025 Financial Results - TradingView
GoodRx Reports Second Quarter 2025 Results - Yahoo Finance
What makes GoodRx Holdings Inc. stock price move sharplyRisk Balanced Picks for Safer Trading - Newser
What data driven models say about GoodRx Holdings Inc.’s futureAlgorithmic Prediction of Market Breakouts - Newser
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 40% Potential Upside and Market Positioning - DirectorsTalk Interviews
Earnings Chart Overlay Points to GoodRx Holdings Inc. UpsideWeekly Watchlist of High Movers Released - beatles.ru
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Goodrx Holdings Inc (GDRX) 財務データ
収益
当期純利益
現金流量
EPS
Goodrx Holdings Inc (GDRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | 10% Owner |
Jul 03 '25 |
Sale |
4.80 |
10,677 |
51,226 |
0 |
4.67%
大文字化:
|
ボリューム (24 時間):